Treatment
Comparator clinical trials
We’re tracking 1,749 recruiting studies that include Comparator, each written for real people, not researchers, below.
Recruiting studies
- NCT06918847Recruiting
Comparing myofascial release vs. cupping for restless leg and knee OA
This study compares two hands-on therapies – myofascial release (gentle stretching of connective tissue) and cupping (using suction cups on the skin) – to see which one better improves quality of life for people who have both restless leg syndrome and knee osteoarthritis. If you have both conditions, you may be able to join.
Karachi, SindhAges 40–70 - NCT06919029Recruiting
New insulin pump study for children with new type 1 diabetes
This study tests a new insulin pump system (MiniMed 780G) in children aged 7-17 who were recently diagnosed with type 1 diabetes. It aims to see if this pump helps control blood sugar better and improves quality of life compared to standard insulin shots or older pumps.
AthensAges 7–17 - NCT06919328Recruiting
Testing a new form of Niagen for energy and fatigue
This trial tests how well a new injectable form of Niagen (a supplement that may boost cellular energy) is absorbed and tolerated compared to NAD+. It may help if you are between 40 and 65, live near the study site, and feel unusually tired.
Huntsville, AlabamaAges 40–65 - NCT06920303Recruiting
Comparing two tests for stroke diagnosis
This trial compares a non-invasive ultrasound test (Transcranial Colour Coded Duplex) to a CT angiography scan for diagnosing stroke. It may help find a simpler and safer way to assess strokes and transient ischemic attacks (mini-strokes).
SohagAges Any age - NCT06921395RecruitingPhase 4
Comparing two fertility drugs for IVF in women under 40
This trial tests how well and safely a new drug (Fang Le Shu) works compared to a standard drug (Guo Na Fen) for stimulating the ovaries to produce eggs for IVF. It may help women who have had trouble getting pregnant for at least a year.
ZhengzhouAges 20–39 - NCT06922084RecruitingPhase 4
Comparing three types of artificial lens implants for cataract surgery
This study tests different artificial lens implants (called intraocular lenses or IOLs) to see which gives the best vision after cataract surgery. If you have cataracts in both eyes and need surgery, you may be able to join.
Plymouth Meeting, PennsylvaniaAges 40 years+ - NCT06923111Recruiting
Xromi safety study for children under 2 with sickle cell disease
This study is checking how safe and effective Xromi is for babies and toddlers (under 2 years old) with sickle cell disease. It compares kids who take Xromi to those who don't, to see if it helps prevent problems.
HamburgAges 9 months–1.9 years - NCT06926140Recruiting
Acupuncture with immunotherapy for advanced lung cancer
This trial tests if adding acupuncture to standard immunotherapy and chemotherapy helps people with advanced lung cancer. It is for those who have not had treatment before and whose tumors have low PD-L1 levels.
Hefei, AnhuiAges 18–75 - NCT06930365Recruiting
Moisturizer study for eczema and healthy skin
This trial compares two moisturizers for people with eczema (moderate rash) and healthy volunteers. It looks at how well they work and how the skin tolerates them after using a steroid cream.
Batumi, AdjaraAges 18 years+ - NCT06932562RecruitingPhase 3
Testing linvoseltamab vs standard care for myeloma patients not eligible for transplant
This trial compares a new drug called linvoseltamab to standard treatments for multiple myeloma. It is for people who cannot have a stem cell transplant and have not had extensive prior therapy.
AdelaideAges 18 years+ - NCT06932614Recruiting
Growth factor vs PRP for knee arthritis
This trial compares two injections—a special growth factor treatment and a platelet-rich plasma (PRP) injection—to see which works better for knee osteoarthritis. It aims to help people with mild to moderate knee arthritis who have had pain for at least 3 months.
TaipeiAges 20–80 - NCT06932848Recruiting
Curcumin gel for treating oral lichen planus
This trial tests if a curcumin nanogel can help heal painful sores from oral lichen planus compared to a standard corticosteroid gel. If you have this condition, you may be able to join.
BangkokAges 18 years+ - NCT06935188RecruitingPhase 2
Dalpiciclib plus cetuximab for certain head and neck cancers
This trial tests a new combination of two drugs (dalpiciclib and cetuximab) versus cetuximab alone for people with head and neck cancer that is HPV-negative, has not responded to prior immunotherapy, and is not curable with surgery. The goal is to see if the combination works better.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06936215RecruitingPhase 3
Baricitinib vs methotrexate for skin tightening in scleroderma
This study tests if baricitinib (a daily pill) is better than methotrexate (a common treatment) at reducing skin tightening in people with a severe type of scleroderma called diffuse cutaneous systemic sclerosis. It may help if your skin is getting tighter and you have been diagnosed in the last 5 years.
DhakaAges 18 years+ - NCT06937892Recruiting
Metacognitive therapy vs. Cognitive therapy for anxiety
This study compares two different types of therapy for anxiety disorders: metacognitive therapy (which focuses on how you think about your thoughts) versus cognitive-behavioral therapy (which works on changing thoughts and behaviors). It may help you find which approach works best for you.
StockholmAges 18 years+ - NCT06938984Recruiting
Human TECAR therapy for exercise recovery in men
This trial tests if TECAR therapy, a type of heat treatment, can help prepare your muscles before exercise and speed up recovery afterwards. It is for physically active men without recent leg injuries.
São Paulo, São PauloAges 18–35 - NCT06940050Recruiting
Gum graft study for lower jaw recessions
This study compares two gum grafting methods (one using a special collagen material plus soft tissue, the other using soft tissue alone) to treat multiple gum recessions on the lower jaw. It may help find a better way to cover exposed roots and improve gum health.
Ghent, Oost-VlaanderenAges 18 years+ - NCT06940505Recruiting
Follow-up from home for early larynx cancer
This trial tests if follow-up appointments from home, using video calls, work just as well as in-person visits for people treated for early-stage larynx cancer. It may save you time and travel.
Groningen, Provincie GroningenAges 18 years+ - NCT06941389Recruiting
Comparing stem cell transplant vs standard therapy for sickle cell disease
This study compares two treatment approaches for children with sickle cell anemia: a stem cell transplant from a matched family donor versus continuing regular disease-modifying medicines. It aims to see which treatment works better over time.
Birmingham, AlabamaAges 3–20 - NCT06942910RecruitingPhase 2
New combination therapy for chronic kidney disease with high proteinuria
This study tests a combination of two drugs (zibotentan and dapagliflozin) compared to dapagliflozin alone in people with chronic kidney disease and high protein in their urine. The goal is to see if the combination works better at protecting your kidneys.
AramilAges 18 years+ - NCT06945029Recruiting
Comparing two airway devices for children having surgery
This study compares two devices used to help children breathe during surgery. It will see which one works best for placing a breathing tube through a scope in children aged 4 to 8 years old.
Cairo, Giza GovernorateAges 4–8 - NCT06947980RecruitingPhase 2
Study of CM512 for moderate-to-severe atopic dermatitis
This trial tests a new treatment called CM512 for people with moderate-to-severe eczema (atopic dermatitis). It aims to see if the drug can improve skin symptoms like itching and rash.
BeijingAges 18–75 - NCT06950203Recruiting
Fish oil supplement for sperm quality
This study tests whether a special fish oil supplement (EPAX EVOLVE 05) can improve sperm movement in men with low sperm motility. It may help if you have been told your sperm are not moving well and you are willing to take a sperm test.
OsloAges 18–55 - NCT06952478RecruitingPhase 3
Comparing a new injectable multiple myeloma drug to Darzalex Faspro
This trial compares a new injectable medicine (CT-P44) to an approved one (Darzalex Faspro), both given with lenalidomide and dexamethasone, for people whose multiple myeloma has come back or stopped responding to treatment. It aims to see if the new option works just as well.
Taipei, Beitou DistrictAges 18 years+
Common questions
- Are there clinical trials studying Comparator?
- Yes. Clin2 currently lists 1,749 recruiting studies that include Comparator, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Comparator trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Comparator an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Comparator or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.